FRAMINGHAM – Framingham Mayor Yvonne Spicer cut the ribbon for the new Sanofi Genzyme manufacturing plant at 68 New York Avenue this afternoon, October 15 in Framingham.
Today, Sanofi, headquartered in France, opened a digitally-enabled manufacturing facility – one of the first of its kind in the world – to develop transformative treatments for patients while providing significant environmental waste reduction.
Sanofi CEO Paul Hudson, who started with the company on September 1, attended the ceremony in Framingham, along with Massachusetts Governor Charlie Baker.
The new plant represents a more than $300 million investment by Sanofi.
Sanofi Genzyme manufactures several products in Framingham including Fabry Disease enzyme replacement therapy Fabrazyme.
Sanofi said the new plant will manufacture products in the Sanofi Genzyme’s Specialty Care portfolio.
Details of which biological products will be made at the latest facility on site remain undisclosed, other than being described as products in Sanofi Genzyme’s Specialty Care portfolio.